$OYST Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oyster Point Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Oyster Point Pharma, Inc.. Get notifications about new insider transactions in Oyster Point Pharma, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2021 | OYST | Oyster Point Pharm ... | WEISNER AIMEE S | Director | Option Exercise | A | 17.74 | 5,199 | 92,230 | 5,199 | |
Jun 09 2021 | OYST | Oyster Point Pharm ... | WEISNER AIMEE S | Director | Grant | A | 0.00 | 3,466 | 0 | 33,191 | 29.7 K to 33.2 K (+11.66 %) |
Jun 09 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Option Exercise | A | 17.74 | 5,199 | 92,230 | 5,199 | |
Jun 09 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Grant | A | 0.00 | 3,466 | 0 | 10,066 | 6.6 K to 10.1 K (+52.52 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 2,018 | 0 | 8,430 | 10.4 K to 8.4 K (-19.31 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | J | 0.00 | 193 | 0 | 7,358 | 7.2 K to 7.4 K (+2.69 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 82,486 | 0 | 0 | 82.5 K to 0 (-100.00 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | J | 0.00 | 82,486 | 0 | 82,486 | 0 to 82.5 K |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 320,340 | 0 | 1,361,590 | 1.7 M to 1.4 M (-19.05 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 642 | 0 | 1,273 | 631 to 1.3 K (+101.74 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 10,302 | 0 | 20,604 | 10.3 K to 20.6 K (+100.00 %) |
Apr 05 2021 | OYST | Oyster Point Pharm ... | Eliades George Christopher | Director | Grant | A | 0.00 | 1,650 | 0 | 21,585 | 19.9 K to 21.6 K (+8.28 %) |
Apr 05 2021 | OYST | Oyster Point Pharm ... | Eliades George Christopher | Director | Grant | A | 0.00 | 19,935 | 0 | 19,935 | 0 to 19.9 K |
Apr 02 2021 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Option Exercise | M | 1.02 | 10,000 | 10,200 | 494,774 | |
Apr 02 2021 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Buy | M | 1.02 | 10,000 | 10,200 | 50,898 | 40.9 K to 50.9 K (+24.45 %) |
Mar 30 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 1,990 | 0 | 10,448 | 12.4 K to 10.4 K (-16.00 %) |
Mar 30 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 82,491 | 0 | 0 | 82.5 K to 0 (-100.00 %) |
Mar 30 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 82,491 | 0 | 82,491 | 0 to 82.5 K |
Mar 30 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 320,368 | 0 | 1,681,930 | 2 M to 1.7 M (-16.00 %) |
Mar 30 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 1,990 | 0 | 10,448 | 12.4 K to 10.4 K (-16.00 %) |
Mar 30 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | J | 0.00 | 193 | 0 | 7,165 | 7 K to 7.2 K (+2.77 %) |
Mar 30 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 82,491 | 0 | 0 | 82.5 K to 0 (-100.00 %) |
Mar 30 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | J | 0.00 | 82,491 | 0 | 82,491 | 0 to 82.5 K |
Mar 30 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 320,368 | 0 | 1,681,930 | 2 M to 1.7 M (-16.00 %) |
Mar 30 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 631 | 0 | 631 | 0 to 631 |
Mar 30 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 631 | 0 | 631 | 0 to 631 |
Mar 30 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 10,302 | 0 | 10,302 | 0 to 10.3 K |
Mar 30 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 10,302 | 0 | 10,302 | 0 to 10.3 K |
Feb 26 2021 | OYST | Oyster Point Pharm ... | Lochner Daniel | Chief Financial Off ... | Option Exercise | M | 11.51 | 9,109 | 104,845 | 184,841 | |
Feb 26 2021 | OYST | Oyster Point Pharm ... | Lochner Daniel | Chief Financial Off ... | Buy | M | 11.51 | 9,109 | 104,845 | 34,631 | 25.5 K to 34.6 K (+35.69 %) |
Feb 23 2021 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Option Exercise | M | 1.02 | 10,000 | 10,200 | 504,774 | |
Feb 23 2021 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Buy | M | 1.02 | 10,000 | 10,200 | 40,898 | 30.9 K to 40.9 K (+32.36 %) |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 5,607 | 0 | 0 | 5.6 K to 0 (-100.00 %) |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 5,607 | 0 | 5,607 | 0 to 5.6 K |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 6,500 | 0 | 0 | 6.5 K to 0 (-100.00 %) |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 6,500 | 0 | 6,500 | 0 to 6.5 K |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 325,000 | 0 | 2,236,888 | 2.6 M to 2.2 M (-12.69 %) |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | J | 0.00 | 372 | 0 | 6,972 | 6.6 K to 7 K (+5.64 %) |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 5,607 | 0 | 0 | 5.6 K to 0 (-100.00 %) |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | J | 0.00 | 5,607 | 0 | 5,607 | 0 to 5.6 K |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 6,500 | 0 | 0 | 6.5 K to 0 (-100.00 %) |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | J | 0.00 | 6,500 | 0 | 6,500 | 0 to 6.5 K |
Feb 19 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 325,000 | 0 | 2,236,888 | 2.6 M to 2.2 M (-12.69 %) |
Dec 14 2020 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 27,942 | 0 | 27,942 | 0 to 27.9 K |
Dec 14 2020 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Sell | J | 0.00 | 955,392 | 0 | 0 | 955.4 K to 0 (-100.00 %) |
Oct 13 2020 | OYST | Oyster Point Pharm ... | ATIEH MICHAEL G | Director | Grant | A | 0.00 | 4,400 | 0 | 19,695 | 15.3 K to 19.7 K (+28.77 %) |
Oct 13 2020 | OYST | Oyster Point Pharm ... | ATIEH MICHAEL G | Director | Grant | A | 0.00 | 15,295 | 0 | 15,295 | 0 to 15.3 K |
Sep 28 2020 | OYST | Oyster Point Pharm ... | Lochner Daniel | Chief Financial Off ... | Option Exercise | M | 11.51 | 4,000 | 46,040 | 193,950 | |
Sep 28 2020 | OYST | Oyster Point Pharm ... | Lochner Daniel | Chief Financial Off ... | Buy | M | 11.51 | 4,000 | 46,040 | 14,300 | 10.3 K to 14.3 K (+38.83 %) |
Aug 12 2020 | OYST | Oyster Point Pharm ... | Lochner Daniel | Chief Financial Off ... | Option Exercise | M | 11.51 | 4,000 | 46,040 | 197,950 | |
Aug 12 2020 | OYST | Oyster Point Pharm ... | Lochner Daniel | Chief Financial Off ... | Buy | M | 11.51 | 4,000 | 46,040 | 4,000 | 0 to 4 K |
Aug 11 2020 | OYST | Oyster Point Pharm ... | Snisarenko John | Chief Commercial Of ... | Buy | P | 25.97 | 4,000 | 103,880 | 7,000 | 3 K to 7 K (+133.33 %) |
Jul 30 2020 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Option Exercise | M | 1.02 | 5,000 | 5,100 | 514,774 | |
Jul 30 2020 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Buy | M | 1.02 | 5,000 | 5,100 | 5,000 | 0 to 5 K |
Jun 10 2020 | OYST | Oyster Point Pharm ... | WEISNER AIMEE S | Director | Grant | A | 0.00 | 6,600 | 0 | 29,725 | 23.1 K to 29.7 K (+28.54 %) |
Jun 10 2020 | OYST | Oyster Point Pharm ... | Tsai Benjamin | Director | Grant | A | 0.00 | 6,600 | 0 | 6,600 | 0 to 6.6 K |
Jun 10 2020 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Grant | A | 0.00 | 6,600 | 0 | 6,600 | 0 to 6.6 K |
Jun 10 2020 | OYST | Oyster Point Pharm ... | Murray Mark Anthony | Director | Grant | A | 0.00 | 6,600 | 0 | 115,047 | 108.4 K to 115 K (+6.09 %) |
Jun 10 2020 | OYST | Oyster Point Pharm ... | Ackermann Michael | Director | Grant | A | 0.00 | 14,805 | 0 | 152,162 | 137.4 K to 152.2 K (+10.78 %) |
Jun 10 2020 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Grant | A | 0.00 | 6,600 | 0 | 6,600 | 0 to 6.6 K |
Jun 10 2020 | OYST | Oyster Point Pharm ... | Behbahani Ali | Director | Grant | A | 0.00 | 6,600 | 0 | 6,600 | 0 to 6.6 K |
Jun 10 2020 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Grant | A | 0.00 | 6,600 | 0 | 6,600 | 0 to 6.6 K |
Jun 10 2020 | OYST | Oyster Point Pharm ... | Behbahani Ali | Director | Grant | A | 0.00 | 6,600 | 0 | 6,600 | 0 to 6.6 K |
May 21 2020 | OYST | Oyster Point Pharm ... | InvOpps GP IV, L.L.C. | Director | Buy | P | 28.00 | 119,393 | 3,343,004 | 1,850,818 | 1.7 M to 1.9 M (+6.90 %) |
May 21 2020 | OYST | Oyster Point Pharm ... | InvOpps GP IV, L.L.C. | Director | Buy | P | 28.00 | 59,178 | 1,656,984 | 917,768 | 858.6 K to 917.8 K (+6.89 %) |
Feb 05 2020 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Option Exercise | A | 32.65 | 211,533 | 6,906,552 | 211,533 | |
Feb 05 2020 | OYST | Oyster Point Pharm ... | Snisarenko John | Chief Commercial Of ... | Option Exercise | A | 32.65 | 72,648 | 2,371,957 | 72,648 | |
Nov 06 2019 | OYST | Oyster Point Pharm ... | InvOpps GP IV, L.L.C. | Director | Option Exercise | C | 0.00 | 1,230,050 | 0 | 0 | |
Nov 06 2019 | OYST | Oyster Point Pharm ... | InvOpps GP IV, L.L.C. | Director | Option Exercise | C | 0.00 | 609,965 | 0 | 0 | |
Nov 06 2019 | OYST | Oyster Point Pharm ... | InvOpps GP IV, L.L.C. | Director | Buy | P | 16.00 | 501,375 | 8,022,000 | 1,731,425 | 1.2 M to 1.7 M (+40.76 %) |
Nov 06 2019 | OYST | Oyster Point Pharm ... | InvOpps GP IV, L.L.C. | Director | Buy | P | 16.00 | 248,625 | 3,978,000 | 858,590 | 610 K to 858.6 K (+40.76 %) |
Nov 06 2019 | OYST | Oyster Point Pharm ... | InvOpps GP IV, L.L.C. | Director | Buy | C | 0.00 | 1,230,050 | 0 | 1,230,050 | 0 to 1.2 M |
Nov 06 2019 | OYST | Oyster Point Pharm ... | InvOpps GP IV, L.L.C. | Director | Buy | C | 0.00 | 609,965 | 0 | 609,965 | 0 to 610 K |
Nov 05 2019 | OYST | Oyster Point Pharm ... | Snisarenko John | Chief Commercial Of ... | Buy | P | 16.00 | 3,000 | 48,000 | 3,000 | 0 to 3 K |
Nov 05 2019 | OYST | Oyster Point Pharm ... | Lochner Daniel | Chief Financial Off ... | Buy | P | 16.00 | 6,300 | 100,800 | 6,300 | 0 to 6.3 K |
Nov 05 2019 | OYST | Oyster Point Pharm ... | OYSTER POINT PHARMA I, LLC | 10% Owner | Option Exercise | C | 0.00 | 955,392 | 0 | 0 | |
Nov 05 2019 | OYST | Oyster Point Pharm ... | OYSTER POINT PHARMA I, LLC | 10% Owner | Buy | C | 0.00 | 955,392 | 0 | 955,392 | 0 to 955.4 K |
Nov 05 2019 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Buy | P | 16.00 | 1,000 | 16,000 | 1,000 | 0 to 1,000 |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Vida Ventures, LLC | 10% Owner | Option Exercise | C | 0.00 | 778,468 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Vida Ventures, LLC | 10% Owner | Buy | P | 16.00 | 185,000 | 2,960,000 | 963,468 | 778.5 K to 963.5 K (+23.76 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Vida Ventures, LLC | 10% Owner | Buy | C | 0.00 | 778,468 | 0 | 778,468 | 0 to 778.5 K |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Falcon Vision LLC | Option Exercise | C | 0.00 | 884,622 | 0 | 0 | ||
Nov 04 2019 | OYST | Oyster Point Pharm ... | Falcon Vision LLC | Buy | P | 16.00 | 155,000 | 2,480,000 | 1,039,622 | 884.6 K to 1 M (+17.52 %) | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Falcon Vision LLC | Buy | C | 0.00 | 884,622 | 0 | 884,622 | 0 to 884.6 K | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | KKR Fund Holdings L.P. | Option Exercise | C | 0.00 | 884,622 | 0 | 0 | ||
Nov 04 2019 | OYST | Oyster Point Pharm ... | KKR Fund Holdings L.P. | Buy | P | 16.00 | 155,000 | 2,480,000 | 1,039,622 | 884.6 K to 1 M (+17.52 %) | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | KKR Fund Holdings L.P. | Buy | C | 0.00 | 884,622 | 0 | 884,622 | 0 to 884.6 K | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 1,061,547 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 3,606,282 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 16.00 | 935,000 | 14,960,000 | 5,925,287 | 5 M to 5.9 M (+18.74 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,061,547 | 0 | 4,990,287 | 3.9 M to 5 M (+27.02 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,606,282 | 0 | 3,928,740 | 322.5 K to 3.9 M (+1,118.37 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 45,529 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Buy | C | 0.00 | 45,529 | 0 | 367,987 | 322.5 K to 368 K (+14.12 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 566,158 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 495,388 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,941,500 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,654,359 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 10,420 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 437,500 | 7,000,000 | 1,003,658 | 566.2 K to 1 M (+77.28 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 566,158 | 0 | 566,158 | 0 to 566.2 K |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 125,000 | 2,000,000 | 2,561,888 | 2.4 M to 2.6 M (+5.13 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 495,388 | 0 | 2,436,888 | 1.9 M to 2.4 M (+25.52 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 1,941,500 | 0 | 1,941,500 | 0 to 1.9 M |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 27,500 | 440,000 | 2,002,298 | 2 M to 2 M (+1.39 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 1,654,359 | 0 | 1,974,798 | 320.4 K to 2 M (+516.28 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 10,420 | 0 | 12,438 | 2 K to 12.4 K (+516.35 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Option Exercise | C | 0.00 | 566,158 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Option Exercise | C | 0.00 | 495,388 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Option Exercise | C | 0.00 | 1,941,500 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | P | 16.00 | 437,500 | 7,000,000 | 1,003,658 | 566.2 K to 1 M (+77.28 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | C | 0.00 | 566,158 | 0 | 566,158 | 0 to 566.2 K |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | P | 16.00 | 125,000 | 2,000,000 | 2,561,888 | 2.4 M to 2.6 M (+5.13 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | C | 0.00 | 495,388 | 0 | 2,436,888 | 1.9 M to 2.4 M (+25.52 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | C | 0.00 | 1,941,500 | 0 | 1,941,500 | 0 to 1.9 M |
Nov 04 2019 | OYST | Oyster Point Pharm ... | WEISNER AIMEE S | Director | Grant | A | 0.00 | 23,125 | 0 | 23,125 | 0 to 23.1 K |
Nov 04 2019 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Option Exercise | C | 0.00 | 955,392 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Option Exercise | C | 0.00 | 1,654,359 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Option Exercise | C | 0.00 | 10,420 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | C | 0.00 | 955,392 | 0 | 955,392 | 0 to 955.4 K |
Nov 04 2019 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | P | 16.00 | 27,500 | 440,000 | 2,002,298 | 2 M to 2 M (+1.39 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | C | 0.00 | 1,654,359 | 0 | 1,974,798 | 320.4 K to 2 M (+516.28 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | C | 0.00 | 10,420 | 0 | 12,438 | 2 K to 12.4 K (+516.35 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Murray Mark Anthony | Director | Option Exercise | C | 0.00 | 106,517 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Murray Mark Anthony | Director | Buy | C | 0.00 | 106,517 | 0 | 108,447 | 1.9 K to 108.4 K (+5,519.02 %) |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ackermann Michael | Director | Option Exercise | C | 0.00 | 140,567 | 0 | 0 | |
Nov 04 2019 | OYST | Oyster Point Pharm ... | Ackermann Michael | Director | Buy | C | 0.00 | 140,567 | 0 | 140,567 | 0 to 140.6 K |
Page: 1